Trimethoprim-sulphamethoxazole in enteric fevers.

Area of Science:

• Infectious Diseases
• Pharmacology
• Internal Medicine

Background:

• Enteric fever and Brucella abortus infections pose significant public health challenges.
• Effective and safe antimicrobial therapies are crucial for managing these infections.

Purpose of the Study:

• To evaluate the efficacy and safety of trimethoprim-sulphamethoxazole in treating patients with enteric fever and Brucella abortus infection.
• To assess the ease of administration of trimethoprim-sulphamethoxazole in critically ill patients.

Main Methods:

• A cohort of 14 patients (13 with enteric fever, 1 with Brucella abortus infection) received trimethoprim-sulphamethoxazole treatment.
• Clinical improvement and adverse events were monitored.

Main Results:

• Rapid clinical improvement was observed in all patients treated with trimethoprim-sulphamethoxazole.
• No adverse side-effects were reported during the treatment period.
• The medication was easily administered, even to patients who were toxic and delirious.

Conclusions:

• Trimethoprim-sulphamethoxazole is an effective and well-tolerated treatment for enteric fever and Brucella abortus infections.
• Its ease of administration makes it a practical option for managing severely ill patients.